FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?
Paradigm Biopharmaceuticals (ASX:PAR) has confirmed that it will use a twice weekly…
Paradigm Biopharmaceuticals Limited.. (ASX:PAR)
About Paradigm Biopharmaceuticals Limited..
Key Information
PAR In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 13/12/2024 | Cleansing Notice | 132.72KB | 397 |
| 13/12/2024 | Application for quotation of securities - PAR | 15.46KB | 381 |
| 09/12/2024 | Price Sensitive PS PAR Capital Raising Presentation | 9.28MB | 29K |
| 09/12/2024 | Proposed issue of securities - PAR | 15.33KB | 436 |
| 09/12/2024 | Price Sensitive PS Successful Completion of $16M Placement for Phase 3 | 416.01KB | 33K |
| 05/12/2024 | Change of Director's Interest Notice | 183.07KB | 557 |
| 05/12/2024 | Change of Director's Interest Notice | 5.71KB | 1.3K |
| 05/12/2024 | Price Sensitive PS Trading Halt | 285.81KB | 85K |